These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 3112096
1. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods. Trimble KA, Clark RB, Sanders WE, Frankel JW, Cacciatore R, Valdez H. J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096 [Abstract] [Full Text] [Related]
2. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria. Texier-Maugein J, Mormède M, Fourche J, Bébéar C. Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050 [Abstract] [Full Text] [Related]
3. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. Steadham JE, Stall SK, Simmank JL. Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885 [Abstract] [Full Text] [Related]
4. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains]. Thomas L, Naumann P, Crea A. Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424 [Abstract] [Full Text] [Related]
5. Preliminary study of the in vitro activity of irloxacin against mycobacteria. Casal M, Gutierrez J, Ruiz P, Moreno G. Chemotherapy; 1995 Nov; 41(3):204-7. PubMed ID: 7656667 [Abstract] [Full Text] [Related]
14. Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria. Salfinger M, Hohl P, Kafader FM. J Antimicrob Chemother; 1988 Oct; 22 Suppl D():55-63. PubMed ID: 3144550 [Abstract] [Full Text] [Related]
15. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. Wallace RJ, Nash DR, Steele LC, Steingrube V. J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069 [Abstract] [Full Text] [Related]
16. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L. Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [Abstract] [Full Text] [Related]
17. [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey]. Ceyhan İ, Özkara Ş, Güler MZ, Dulkar G, Altınsoy R, Vezir S. Mikrobiyol Bul; 2019 Jul; 53(3):330-335. PubMed ID: 31414634 [Abstract] [Full Text] [Related]
18. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method. Udou T. J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338 [Abstract] [Full Text] [Related]
19. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Heifets LB, Lindholm-Levy PJ. Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801 [Abstract] [Full Text] [Related]
20. New antimycobacterial S-alkylisothiosemicarbazones. Waisser K, Heinisch L, Slosárek M, Janota J. Folia Microbiol (Praha); 2005 Dec; 50(6):479-81. PubMed ID: 16681143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]